Company Name [asc] |
Country |
OncoNano Medicine Limited |
Ireland |
Onconova Europe GmbH |
Germany |
Oncopeptides AB (publ) |
Sweden |
Oncoradiomics S.A. |
Belgium |
Oncoral Pharma ApS |
Denmark |
Oncorena AB |
Sweden |
Oncoscience GmbH |
Germany |
Oncostellae S.L. |
Spain |
OncoZenge AB |
Sweden |
One-carbon Therapeutics AB |
Sweden |
OneChain Immunotherapeutics, S.L. |
Spain |
Oniria Therapeutics S.L. |
Spain |
Onkogen Kft. |
Hungary |
onkovis GmbH |
Germany |
Onni Biotechnologies Oy |
Finland |
OP Pharma SRL |
Italy |
Op2Lysis |
France |
OPERON, S.A. |
Spain |
Optimal Regulatory Solutions, S.L.U. |
Spain |
Opus Materia Ltd |
Greece |
Oranda Therapeutics Limited |
Ireland |
Oresund Pharma ApS |
Denmark |
Orexa B.V. |
Netherlands |
ORKEO |
France |
ORNYX OÜ |
Estonia |
Orphalan |
France |
ORPHELIA Pharma |
France |
Orphelion AB |
Sweden |
Orphix Consulting GmbH |
Germany |
ORYX GmbH & Co. KG |
Germany |
Oryzon Genomics, S.A. |
Spain |
Osalia |
France |
OSE Immunotherapeutics |
France |
OSIVAX |
France |
OT4B |
France |
OvoVet Pharma SRL |
Romania |
Ovum SPF S.L. |
Spain |
Oxcia AB |
Sweden |
Oxolife SL |
Spain |
Ozack ApS |
Denmark |
|